Form 4: Kristina Burow Reports Changes in Beneficial Ownership of Boundless Bio, Inc. (BOLD) Stock

Kristina Burow, a director and 10% owner of Boundless Bio, Inc., reports changes in her beneficial ownership of the company's stock following the company's initial public offering.

Summary

• Kristina Burow, a director and 10% owner of Boundless Bio, Inc. (BOLD), filed a Form 4 with the SEC detailing changes in her beneficial ownership of the company's stock on April 2, 2024.
• The changes involve the conversion of preferred stock into common stock and purchases of common stock in the company's initial public offering.
• Burow's reported transactions include the conversion of Series A, B, and C convertible preferred stock into common stock.
• She also reports purchases of common stock at a price of $16 per share.
• The reported ownership is indirect, held through various ARCH Venture Funds.
• Burow disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting changes in beneficial ownership, which is neutral in sentiment.

Industry Context

Form 4 filings are standard practice for insiders of publicly traded companies to report changes in their ownership positions, providing transparency to investors.

Stakeholder Impact

• Shareholders are informed about changes in ownership by a major shareholder.
• The filing provides transparency regarding insider transactions.

Key Dates